BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22108242)

  • 1. The effects of a telomere destabilizing agent on cancer cell-cycle dynamics--integrated modelling and experiments.
    Hirt BV; Wattis JA; Preston SP; Laughton CA
    J Theor Biol; 2012 Feb; 295():9-22. PubMed ID: 22108242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.
    Leonetti C; Amodei S; D'Angelo C; Rizzo A; Benassi B; Antonelli A; Elli R; Stevens MF; D'Incalci M; Zupi G; Biroccio A
    Mol Pharmacol; 2004 Nov; 66(5):1138-46. PubMed ID: 15304549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism.
    Phatak P; Cookson JC; Dai F; Smith V; Gartenhaus RB; Stevens MF; Burger AM
    Br J Cancer; 2007 Apr; 96(8):1223-33. PubMed ID: 17406367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities.
    Rizzo A; Iachettini S; Zizza P; Cingolani C; Porru M; Artuso S; Stevens M; Hummersone M; Biroccio A; Salvati E; Leonetti C
    J Exp Clin Cancer Res; 2014 Oct; 33(1):81. PubMed ID: 25288403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
    Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
    J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors.
    Leonetti C; Scarsella M; Riggio G; Rizzo A; Salvati E; D'Incalci M; Staszewsky L; Frapolli R; Stevens MF; Stoppacciaro A; Mottolese M; Antoniani B; Gilson E; Zupi G; Biroccio A
    Clin Cancer Res; 2008 Nov; 14(22):7284-91. PubMed ID: 19010844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrative biological approach to the analysis of tissue culture data: application to the antitumour agent RHPS4.
    Johnson LA; Byrne HM; Willis AE; Laughton CA
    Integr Biol (Camb); 2011 Aug; 3(8):843-9. PubMed ID: 21773618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
    Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner.
    Tamakawa RA; Fleisig HB; Wong JM
    Cancer Res; 2010 Nov; 70(21):8684-94. PubMed ID: 20837664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents.
    Martins C; Gunaratnam M; Stuart J; Makwana V; Greciano O; Reszka AP; Kelland LR; Neidle S
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2293-8. PubMed ID: 17276687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-substituted acridines as potent telomeric G-quadruplex ligands.
    Laronze-Cochard M; Kim YM; Brassart B; Riou JF; Laronze JY; Sapi J
    Eur J Med Chem; 2009 Oct; 44(10):3880-8. PubMed ID: 19467742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy.
    Salvati E; Scarsella M; Porru M; Rizzo A; Iachettini S; Tentori L; Graziani G; D'Incalci M; Stevens MF; Orlandi A; Passeri D; Gilson E; Zupi G; Leonetti C; Biroccio A
    Oncogene; 2010 Nov; 29(47):6280-93. PubMed ID: 20802516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RHPS4 G-quadruplex ligand induces anti-proliferative effects in brain tumor cells.
    Lagah S; Tan IL; Radhakrishnan P; Hirst RA; Ward JH; O'Callaghan C; Smith SJ; Stevens MF; Grundy RG; Rahman R
    PLoS One; 2014; 9(1):e86187. PubMed ID: 24454961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor polycyclic acridines. Part 12. Physical and biological properties of 8,13-diethyl-6-methylquino[4,3,2-kl]acridinium iodide: a lead compound in anticancer drug design.
    Missailidis S; Stanslas J; Modi C; Ellis MJ; Robins RA; Laughton CA; Stevens MF
    Oncol Res; 2002; 13(3):175-89. PubMed ID: 12549627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer.
    Mudduluru G; George-William JN; Muppala S; Asangani IA; Kumarswamy R; Nelson LD; Allgayer H
    Biosci Rep; 2011 Jun; 31(3):185-97. PubMed ID: 20815812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs.
    Gardner SN
    Cancer Res; 2000 Mar; 60(5):1417-25. PubMed ID: 10728708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
    Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
    Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
    Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.